Lobbying

University of Pennsylvania Health System's latest lobbying report covers Q2 2026, at $22.7K. The four quarters Q4 2025–Q3 2026 total $58.2K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Medicare/Medicaid.

University of Pennsylvania Health System

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$58.2K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

University of Pennsylvania Health System lobbying by quarter
University of Pennsylvania Health System lobbying by quarter
QuarterAmountReports
Q4 2022$22K1
Q1 2023$21.6K1
Q2 2023$22.3K1
Q3 2023$12.5K1
Q4 2023$22.7K1
Q1 2024$23.8K1
Q2 2024$20.6K1
Q3 2024$20.6K1
Q4 2024$18.5K1
Q1 2025$64.8K1
Q2 2025$52.8K1
Q3 2025$20.6K1
Q4 2025$22.7K1
Q1 2026$12.9K1
Q2 2026$22.7K1
Q3 2026$00

By issue

  • Health issues$17.6K · 2 reports
  • Medicare and Medicaid$17.6K · 2 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES1 reports
  • SENATE1 reports

Firms it paid

Firm
Debrunner & Associates$380.8K15 quarters

Former officials lobbying for it

Former position
ELLEN J KUGLERFederal Legislative ConsultantQ4 2023
KATE FINKELSTEINFederal Legislative ConsultantQ4 2023

Lobbying reports

Filed by
07/20for Q2Debrunner & Associates$22.7K
04/20for Q1Debrunner & Associates$12.9K
01/18for Q4 2025Debrunner & Associates$22.7K
25/10/17for Q3 2025Debrunner & Associates$20.6K
25/07/14for Q2 2025Debrunner & Associates$52.8K
25/04/21for Q1 2025Debrunner & Associates$64.8K
25/01/21for Q4 2024Debrunner & Associates$18.5K
24/10/10for Q3 2024Debrunner & Associates$20.6K
24/07/17for Q2 2024Debrunner & Associates$20.6K
24/04/18for Q1 2024Debrunner & Associates$23.8K
24/01/12for Q4 2023Debrunner & Associates$22.7K
23/10/20for Q3 2023Debrunner & Associates$12.5K
23/07/20for Q2 2023Debrunner & Associates$22.3K
23/04/18for Q1 2023Debrunner & Associates$21.6K
23/01/19for Q4 2022Debrunner & Associates$22K